azadart.org

Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

March 2017 – The Science of Parkinson's

Druggable genome in attention deficit/hyperactivity disorder and

An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

Druggable genome in attention deficit/hyperactivity disorder and

March 2017 – The Science of Parkinson's

Druggable genome in attention deficit/hyperactivity disorder and

FDA-Approved Drugs to Treat ADHD Journal of Psychosocial Nursing and Mental Health Services

Druggable genome in attention deficit/hyperactivity disorder and

Gene mutation discovered that causes language impairment, ADHD and myasthenia

Druggable genome in attention deficit/hyperactivity disorder and

Opportunities for Small Molecule Drug Discovery within the Neural Kinome, Alison Axtman, SGC-UNM

Druggable genome in attention deficit/hyperactivity disorder and

Insights into attention-deficit/hyperactivity disorder from recent genetic studies, Psychological Medicine

Druggable genome in attention deficit/hyperactivity disorder and

Bergen Open Research Archive: Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.

Druggable genome in attention deficit/hyperactivity disorder and

Pharmaceutics, Free Full-Text